The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection
Gregory R. Bluemling, Shuli Mao, Michael G. Natchus, Wendy Painter, Sabue Mulangu, Mark Lockwood, Abel De La Rosa, Trevor Brasel, Jason E. Comer, Alexander N. Freiberg, Alexander A. Kolykhalov, George R. Painter
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection'. Together they form a unique fingerprint.